Telix Pharmaceuticals to acquire QSAM Biosciences and its bone cancer therapy
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited, an Australian company that develops radiopharmaceuticals for cancer diagnosis and treatment, has announced its intention to acquire QSAM Biosciences, Inc.,...